Shire Human Genetic Therapies, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 200 Riverpark Drive, North Reading, Massachusetts (MA) 01864, United States (USA)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3008424653 · DUNS 831834762
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2017-01-05
- VAIDrug Quality Assurance2014-01-30
- VAIDrug Quality Assurance2012-01-06
- NAIDrug Quality Assurance2011-02-16
Drugs this plant is listed as making
1 distinct drugs across 2 products name this site in their FDA label.
- Apadamtase AlfaTakeda Pharmaceuticals America, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.